Spartan Bioscience announces first applications for world's smallest DNA-testing device
July 31st, 2016
Spartan Bioscience today launched the world’s smallest commercial molecular diagnostic device, the Spartan Cube, and announced its first applications. About the size of a coffee cup, or four inches cubed, the Cube enables unprecedented portability and convenience, enabling new applications in fields such as infectious disease, pharmacogenetics, and food and water safety testing.
The Spartan Cube is a PCR-based platform that fully integrates DNA collection, extraction, and analysis, with an intuitive interface that is easy to operate. In addition, the Cube goes from sample to result in 30 minutes, a fraction of the time compared to lab-based testing.
Spartan today announced three assays: Strep A, Apolipoprotein E (APOE), and Legionella.